Kymera Therapeutics, Inc 10-K for FY2021
Kymera Therapeutics, Inc. (KYMR)
10-K
2022-02-24
For: 2021-12-31
View Original
Added on
April 10, 2026
About this 10-K
Kymera Therapeutics, Inc filed this 10-K on February 24, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $72.83M
- up 114.0% from $34.03M a year earlier
- Net loss
- $100.22M
- compared with a net loss of $45.59M a year earlier